LDLR and metabolic syndrome: As the only three ACMG genes featured on the LipidSeq panel include the known FH genes LDLR, APOB, and PCSK9, the LipidSeq approach considerably limits patient exposure to incidental genomic findings unrelated to dyslipidemia.